Related Experiment Video
Updated: Oct 9, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Targeting disorders in unstructured and structured proteins in various diseases
Sinjan Choudhary1, Manu Lopus1, Ramakrishna V Hosur1
1UM-DAE Centre for Excellence in Basic Sciences, University of Mumbai, Vidhyanagri Campus, Kalina, Mumbai 400098, India.
Intrinsically disordered proteins (IDPs) and regions (IDPRs) lack stable structures, enabling diverse functions but causing diseases like cancer and Alzheimer's when malfunctioning. Targeting these disordered proteins offers new therapeutic strategies and drug discovery avenues.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Intrinsically disordered proteins (IDPs) and regions (IDPRs) lack stable structures, challenging traditional protein function theories.
- Their conformational flexibility allows specific yet low-affinity binding to multiple partners, crucial for signaling, recognition, and regulation.
- Dysregulation of IDPs/IDPRs is linked to various human diseases, including cancer, Parkinson's, and Alzheimer's disease.
Purpose of the Study:
- To review diseases associated with protein disorder.
- To summarize therapeutic targeting strategies for intrinsically disordered proteins and regions.
- To highlight the potential of targeting IDPs/IDPRs for novel drug design and discovery.
Main Methods:
- Literature review of protein disorder diseases.
- Analysis of therapeutic targeting methods for IDPs/IDPRs.
- Synthesis of current research on drug discovery for disordered proteins.
Main Results:
- IDPs/IDPRs are implicated in a wide range of human pathologies.
- Targeting IDPs/IDPRs presents unique challenges due to their dynamic nature.
- Various strategies are being developed for therapeutic intervention of disordered proteins.
Conclusions:
- Intrinsically disordered proteins and regions are critical players in human health and disease.
- Targeting IDPs/IDPRs represents a promising frontier for developing novel therapeutics.
- Successful targeting of these proteins could revolutionize rational drug design and discovery.
More Related Videos
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Protein-protein Interfaces
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

